Avance Clinical, a partner for biotechs providing global contract research organization services, has announced the launch of the Renal & Cardiometabolic Center of Excellence
Avance Clinical is proud to announce our attendance at the 10th Annual Outsourcing in Clinical Trials (OCT) Korea 2025, South Korea’s premier clinical outsourcing conference bringing together leaders in biotech and pharmaceutical innovation.
For European biotechs ready to move fast, Australia is the smartest early-phase starting point—and Avance Clinical is the CRO that makes it happen.
Avance Clinical will be exhibiting at the 13th Annual Outsourcing in Clinical Trials Southern California 2025, held on September 23-24 at the Hyatt Regency La Jolla at Aventine, San Diego.
This expert panel will explore how Australia, Taiwan, and South Korea provide a strategic advantage in conducting early, mid, and late-phase oncology trials, offering speed, cost efficiency, and global scalability.
As regulatory uncertainty grows in the United States, US biotechs are increasingly looking to Australia as a stable and predictable launchpad for early-phase clinical trials.
Avance Clinical has further strengthened its presence in Asia with the opening of an office in Taipei, Taiwan.
Avance Clinical is pleased to announce the signing of four Memorandums of Understanding (MOUs) with key clinical trial sites in Taiwan this week.
The success of a biotech drug development program often depends on the relationship it forms with its Clinical Research Organization (CRO) partner.
For early-stage biotech companies, securing funding is often a significant challenge due to the complex and costly nature of drug development.
Avance Clinical is a full-service Contract Research Organization (CRO) with clinical operations in Australia, New Zealand, Asia, North America, and Europe.
Level 22, 91 King William Street
Adelaide, SA
Australia 5000
Phone: +61 8 8249 4788
For all media enquiries: media@avancecro.com